title: Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
authors.forename: L K
authors.initials: LK
authors.lastname: Steinrauf
authors.forename: A R
authors.initials: AR
authors.lastname: Schulz
authors.forename: K W
authors.initials: KW
authors.lastname: Ryder
authors.forename: P W
authors.initials: PW
authors.lastname: Brunn
authors.forename: D
authors.initials: D
authors.lastname: Cook
authors.forename: W
authors.initials: W
authors.lastname: Judy
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects* / Q000627:therapeutic use; D004734:Energy Metabolism / Q000187:drug effects*; D004983:Ethanolamines / Q000009:adverse effects*; D005080:Exercise Test; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
chemical_list: D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D001262:Atenolol; D007741:Labetalol